Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia

Bortezomib, a chemotherapeutic agent used in the treatment of hematologic malignancies, has been associated with multiple forms of lung injury including diffuse alveolar hemorrhage (DAH). We present the first reported case of bortezomib-induced DAH in a patient with plasma cell leukemia. This 59-yea...

Full description

Bibliographic Details
Main Authors: Ingrid M. Wirth, Gregory E. Peters
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007120303828